Mr. Barrett serves as Managing Director.
Mr. Barrett serves on the Board of Directors of American Health Staffing Group and NavaDerm Partners.
His responsibilities range from deal origination and structuring to due diligence, execution and portfolio company monitoring. Mr. Barrett leads BelHealth’s origination efforts. Previously, Mr. Barrett worked as an Associate and Analyst in the healthcare investment banking division of CIT Group, where he focused on M&A and Leveraged Finance transactions. Prior to CIT, Mr. Barrett worked at Thomson Reuters in their Corporate Advisory Services group.
Mr. Barrett received a bachelor’s degree from the University of Virginia.
Harold S. Blue
Mr. Blue is Founder and Managing Partner.
Mr. Blue serves on the Board of Directors of American Health Staffing Group, Beach House, Care Advantage, General Genetics, Geritrex, Integrated Care Physicians, Precision Diagnostics, Quick Care Pharmacy, NavaDerm Partners, and Village Fertility Pharmacy..
Mr. Blue has been actively involved in healthcare private equity for 20 years, in addition to his 18 years as a healthcare entrepreneur and operator. Prior to founding BelHealth, Mr. Blue was Founder and Managing Partner of HealthEdge Investment Partners and Managing Partner of Comvest Partners.
During his career, Mr. Blue has served on the Board of Directors of more than 40 public, and private companies. Prior to his private equity career, Mr. Blue was the founder and entrepreneur of four healthcare companies.
Mr. Drislane is Co-Founder and Managing Partner.
Mr. Drislane serves on the Board of Directors of American Health Staffing Group, Care Advantage, General Genetics, Geritrex, Integrated Care Physicians Beach House, Precision Diagnostics, Quick Care Pharmacy, NavaDerm Partners, and Village Fertility Pharmacy, .
In addition to his corporate responsibilities, Mr. Drislane is on the Advisory Board of the Hoag Neurosciences Institute, which is focused on innovative, multidisciplinary team approaches to disorders of the brain, nerves and spine. Mr. Drislane is also on the Board of Directors of the Cornelia de Lange Syndrome (CdLS) Foundation, an organization that provides a host of services that educate and unite families touched by this little-known genetic syndrome.
Mr. Drislane's prior experience includes 24 years at Electronic Data Systems (EDS) where he was President of the Healthcare Strategic Business Unit; Senior Vice President at Healtheon during the IPO and eventual merger with WebMD; CEO of TC3 Health where he led the sale of the company to Emdeon; and a member of the Operating Committee at HealthEdge Investment Partners.
Mr. Drislane received his Master of Science in Business Administration, Management Information Science, and his Bachelor of Science in Business Administration, Computer Information Science, from California State University in Sacramento.
Michelle A. Gallegos
Ms. Gallegos serves as Controller.
She is responsible for all areas of administration, accounting, finance and human resources for the Fund.
Ms. Gallegos spent 15 years working with individual private equity funds and fund administrators. Most recently she was a Vice President of Securities and Fund Services at Citi Private Equity Services.
She holds a bachelor’s degree from the University of Richmond and an MBA in Accounting from Rutgers University. She also received her license as a Certified Public Accounting from the state of New York in 2000.
Mr. Gurny serves as Senior Associate.
His responsibilities range from deal origination and structuring to due diligence execution and portfolio monitoring. Previously, Mr. Gurny worked as an Associate and Analyst in the Leveraged Finance group of RBS Citizens, where he focused on healthcare transactions.
Mr. Gurny received a bachelor’s degree from Tufts University.
Mr. Kronforst serves as a Managing Director.
Mr. Kronforst serves on the Board of Directors of Village Fertility Pharmacy and Geritrex.
Mr. Kronforst has over a decade of experience in private equity investing, investment banking and management consulting. Mr. Kronforst was previously a Vice President and founding member of Celerant Capital, an operationally focused, middle market private equity firm where he led deal origination, evaluation and structuring. Additionally, Mr. Kronforst acted as a lead due diligence advisor to select Celerant Consulting private equity clients on investments in middle and large cap, healthcare and chemicals companies. Prior to Celerant Capital, Mr. Kronforst was an investment banking Associate at Lehman Brothers and Barclays Capital. Before Lehman Brothers, Mr. Kronforst was a management consultant with Celerant Consulting, where he advised clients and implemented operational improvement and turnaround projects for Fortune 500 and private equity owned businesses in the U.S. and Europe.
Mr. Kronforst received his MBA from the University of North Carolina’s Kenan-Flagler Business School, concentrating in Corporate Finance. He also received a BBA in Finance and Computer Information Systems from the University of Miami.
Mr. Laifer serves as Associate.
His responsibilities range from deal origination and structuring to due diligence, execution and portfolio monitoring. Previously, Mr. Laifer was an Investment Banking Associate in the Healthcare group at Goldman Sachs.
Mr. Laifer received an M.B.A. from the Wharton School of the University of Pennsylvania where he graduated with honors and a B.B.A from Emory University.
April Mercedes Lane
Ms. Lane serves as Office Manager.
Ms. Lane has over 15 years of global assistant experience in Europe and the United States supporting various executive positions. Previously she has worked at New York’s Fisher Brothers / Plaza Construction and LaGuardia’s Airport redevelopment project.
Timothy M. Leahy
Mr. Leahy serves as Managing Director.
Mr. Leahy has two decades of healthcare industry investing experience. He previously served as a Managing Director and Portfolio Manager at Goldman Sachs Asset Management overseeing growth oriented public equity portfolios with a particular focus on healthcare.
He joined Goldman Sachs Asset Management in 2005 as a research analyst following healthcare. Prior to that, he was a senior analyst in the Global Investment Research Division at Goldman Sachs covering the healthcare facilities sector. Additionally, he was a member of the healthcare services team, which was consistently highly ranked in Institutional Investor All-America surveys. He joined Goldman Sachs in 1999 as a financial analyst.
Mr. Leahy began his career at First Union Capital Markets as a research associate analyzing the healthcare services industry.
He holds a bachelor’s degree in Business Administration with a concentration in finance from the University of Richmond.
Mr. Lee serves as a Managing Director.
Mr. Lee serves on the Board of Directors of Care Advantage and Integrated Care Physicians.
Mr. Lee has over 13 years of relevant private equity experience in the lower middle market healthcare sector. Beginning in 2004, Mr. Lee was the Investment Analyst for Commonwealth Associates and the CARE Capital Group, where he first met and worked with several members of the BelHealth team. Starting in 2006, Mr. Lee served as a Principal at HealthEdge Investment Partners (“HealthEdge”), a lower middle market focused healthcare private equity fund that Harold Blue founded in 2005. While at HealthEdge, Mr. Lee was involved in all of the firm’s platform investments and served as a Board member of Woodbury Health Products, Infinity Homecare, and MNG Laboratories.
Mr. Lee has particular expertise in the home health, healthcare consumer products, contract manufacturing and specialty distribution healthcare sectors.
Scott received his BS in Commerce from the University of Virginia with concentrations in Finance, Accounting, and Management.
Mr. Mendham serves as Vice President, Finance.
Mr. Mendham has 20 years of experience in financial and accounting roles. Most recently, Mr. Mendham served as Chief Financial Officer (“CFO”) of Qforma, a leading provider of data analytics services to the pharmaceutical industry and a BelHealth portfolio company. Prior to Qforma, Mr. Mendham served as Vice President, Finance for Advanced Health Media, the industry leader in speaker bureau management and compliance management systems for the pharmaceutical industry. Mr. Mendham leads BelHealth’s financial due diligence and supports the portfolio company CFOs. Mr. Mendham is a Board Observer for all BelHealth portfolio companies
Mr. Miller serves as an Associate.
His responsibilities range from deal origination and structuring to due diligence, execution and portfolio company monitoring. Previously, Mr. Miller was a Senior Investment Banking Analyst at Stephens Inc. where he focused on M&A in the Healthcare and Industrial sectors.
Mr. Miller received a Master’s in Finance with honors from Vanderbilt University’s Owen School of Management and a Bachelor of Science degree from Centre College.
Ms. Paul serves as Executive Assistant and Compliance Paralegal.
Ms. Paul has over 25 years of experience as an executive assistant, paralegal and office manager. Previously, she has worked at McDonald Hopkins, LLC and Greenberg Traurig LP providing support in real estate, litigation, bankruptcy and general corporate matters.
Mr. Spero serves as a Senior Associate.
His responsibilities range from deal origination and structuring to due diligence, execution and portfolio company monitoring. Previously, Mr. Spero worked as an Analyst in the healthcare investment banking division of SunTrust Robinson Humphrey where he focused on M&A, equity and leveraged finance transactions. Mr. Spero began his career at Schneider Downs Corporate Finance, a boutique investment bank focused on lower middle market M&A.
Mr. Spero received his Bachelor of Science in Business Administration from Carnegie Mellon University.
Inder Tallur serves as Senior Managing Director.
He has been a member of the BelHealth team since inception in 2011.
Mr. Tallur serves on the Board of Directors of Quick Care.
He oversees BelHealth’s fundraising efforts and manages the Fund’s limited partner relationships.
Mr. Tallur has over two decades of experience in private equity investing and investment research. He previously spent over 13 years at ComVest Partners, where he focused on investing in micro and small cap companies across a variety of industries including technology and healthcare. Prior to that, he spent five years in the telecommunications and computer industry in India at companies including Digital Equipment Corporation and HCL Technologies.
He received an MBA from Tulane University's A.B. Freeman School of Business in 1994 and an MS in Finance from Boston College in 1995. He also received a BS in Electronics Engineering from Visvesvaraya National Institute of Technology ("VNIT"), Nagpur, India in 1987.
Mr. Weiner serves as a Business Development Associate.
His responsibilities range from sourcing, deal origination and relationship management to structuring, due diligence and execution. Previously, Mr. Weiner worked as an Associate on GE’s Corporate M&A team. He began his career in GE’s Leadership Development Program.
Mr. Weiner received a B.A. in Economics and Philosophy from the University of North Carolina at Chapel Hill, where he graduated cum laude.
Joseph P. Wynne
Mr. Wynne serves as Chief Financial and Administrative Officer.
Mr. Wynne serves on the Board of Directors of Precision Diagnostics.
Mr. Wynne has spent more than 20 years as the Chief Financial Officer in private equity and/or private equity backed small cap companies across a variety of industries. For 10+ years he served as Partner, Chief Financial Officer and Registered Financial Principal of both Commonwealth Associates LP and ComVest Capital Partners, LLC, a private equity merchant bank where he was instrumental in determining the overall strategic direction of the company as a member of the firm’s Executive, Investment and Compensation Committees.
In his role, he conducted the financial due diligence on prospective investments and provided strategic, financial and operational oversight to portfolio companies. Mr. Wynne also served as a core team member that started the ComVest group, including a $35 million venture fund.
In addition, Mr. Wynne was the Chief Financial Officer for several private equity backed companies where he was instrumental in providing debt and equity capital, business/acquisition due diligence, financial restructuring, strategic planning and financial forecasting, as well as overall financial and operational process improvements. Mr. Wynne has also been an entrepreneur and served on the Boards of a number of both public and private companies.
Mr. Wynne holds a bachelor’s degree from Hofstra University and an MBA in Finance from the Stern School of Business at New York University. He also received his license as a Certified Public Accountant from the state of New York in April 1990.
Ms. Yu serves as Vice President.
Ms. Yu observes American Health Staffing Group and Geritrex
Her responsibilities range from deal origination and structuring to due diligence, execution and portfolio company monitoring. Previously, Ms. Yu worked at Warburg Pincus, where she focused on healthcare and consumer investing. Ms. Yu began her career at Goldman Sachs in Mortgages Trading.
Ms. Yu received an A.B. in Physics from Princeton University and an MBA from Stanford Graduate School of Business, where she was an Arjay Miller Scholar.